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ABSTRACT
The serotypes of 53 isolates of Haemophilus influenzae from children with invasive infections were
determined by a conventional slide agglutination test (SAT) and a recently proposed PCR-based method
for serotyping H. influenzae. The PCR assay identified 47 (88.7%) type b isolates, one (1.9%) type e isolate
and five (9.4%) non-typeable isolates. The only discrepancy between the methods was an isolate that
was non-typeable by SAT, but was identified as serotype e by PCR. Of 41 isolates from patients with
meningitis, 39 (95.1%) were type b. Of the five non-typeable isolates, three (60%) were from the blood of
patients with septicaemic pneumonia and two (40%) were from the cerebrospinal fluid of patients with
meningitis. None of the non-typeable isolates appeared to be a capsule-deficient mutant of an
encapsulated H. influenzae strain. Overall, the study confirmed the usefulness of this PCR method for the
serotyping of invasive H. influenzae isolates.
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INTRODUCTION
Haemophilus influenzae is one of the major patho-
genic bacteria causing paediatric infectious dis-
ease. Encapsulated H. influenzae strains are
distinguished from non-typeable (NT) strains by
the presence of one of six structurally and
serologically distinct polysaccharide capsules,
referred to as serotypes a–f. It is well-known that
H. influenzae serotype b strains (Hib), which have
high virulence compared to non-serotype b and
NT strains, constitute a major cause of invasive
infections such as meningitis, sepsis and epiglot-
titis in children [1]. Recently, a PCR method has
been devised for serotyping H. influenzae strains,
and was shown to have high sensitivity and
specificity compared with the traditional slide
agglutination test (SAT) [2].
The H. influenzae capsulation locus cap is a DNA
fragment of c. 1.7 kb that is common to all strains
that are typeable on the basis of their capsular
structure. It consists of three regions (regions 1–3).
All serotypeable strains share regions 1 and 3, but
differ in region 2, which is considered to be a
type-specific region. Most Hib strains possess two
copies of cap, namely an intact copy and a second
copy that has lost 1.2 kb of flanking region
containing the bexA gene, which is necessary for
capsule export [3,4]. A pair of primers (HI-1 and
HI-2) has been designed to amplify the bexA gene,
and these can be used to differentiate capsular
strains from NT strains [5]. In addition, it has
been reported that Hib cap can be duplicated or
reduced in the flanking region containing the
bexA gene during a homologous recombination
process. Strains that lose the bexA gene cannot be
identified by SAT, as they are unable to express
the capsular polysaccharide. Similarly, they can-
not be identified with primers HI-1 and HI-2, but
can be detected by PCR with primers specific for
type b [5].
In the USA, Hib vaccine was introduced in 1988
and has been used widely since 1990. As a
consequence, the prevalence of infectious diseases
caused by Hib has decreased dramatically, while
a trend towards an increase in the incidence of
diseases caused by NT H. influenzae strains or
those belonging to other capsular serotypes has
Corresponding author and reprint requests: N. Ishiwada,
Chiba 260-8670, Chuo-ku, Inohana, 1-8-1, Japan
E-mail: ishiwada@faculty.chiba-u.jp
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
been noted [6,7]. In contrast, the Hib vaccine
has not yet been introduced in Japan. Thus,
H. influenzae is still a leading cause of paediatric
invasive infections, especially meningitis, in Japan
[8]. In addition, paediatric invasive infections
associated with non-type b and NT H. influenzae
strains have not been well-documented. There-
fore, it is necessary to determine the precise
incidence rate of Hib and other encapsulated or
NT H. influenzae strains by a technique that yields
unequivocal results. The present study presents
the results of a comparative serotypic character-
isation by PCR [2,5] and SAT of H. influenzae
isolates recovered from Japanese paediatric
patients with invasive infection.
MATERIALS AND METHODS
Bacterial isolates
From January 2000 to May 2003, 53 isolates of H. influenzae
were recovered from various sites of 53 paediatric patients
with invasive infections. The patients were admitted either to
the Department of Paediatrics of Chiba University Hospital or
to ten other hospitals located in various areas throughout
Japan. The isolates were from cerebrospinal fluid in cases of
meningitis, or from blood. The isolates were stored at )80C
until they were investigated.
Bacterial identification
All isolates were identified as H. influenzae by standard
laboratory methods on the basis of colony morphology, Gram’s
stain, X- and V-factor requirement, and negative porphyrin
tests. The following six strainswere used as positive controls for
serotypes a, b, c, d, e and f, respectively: ATCC 9006, ATCC
10211, ATCC 9007, ATCC 9332, ATTC 8142 and ATCC 9833. A
further five strains, namely Staphylococcus aureus ATCC 25923,
H. influenzae ATCC 49766 (NT), Moraxella catarrhalis (clinical
isolate), Streptococcus sp. (clinical isolate) and Streptococcus
pneumoniae (clinical isolate), were used as negative controls.
Serotype determination by slide agglutination
Sub-cultures (20–24 h) of the H. influenzae isolates were tested
initially with a commercially available slide agglutination kit
for type b (Phadebact Haemophilus test; Pharmacia, Tokyo,
Japan). Non-serotype b strains were then investigated further
by counter-immunoelectrophoresis with antisera specific for
serotypes a–f (Denka Seiken, Tokyo, Japan).
Serotype determination by PCR
Bacterial DNA was prepared by a modification of the methods
described by LaClaire et al. [2] and Falla et al. [5]. Rapid DNA
extraction was performed by resuspending a sweep of eight
H. influenzae colonies (from an 18–20-h subculture on chocolate
agar) in 25 lL of sterile distilled water and boiling for 3 min.
The cell debris was pelleted by centrifugation at 2000 g for
2 min, and 20 lL of supernatant was stored at ) 20C until
required. Primers HI-1 and HI-2 [5] were used to detect the
bexA gene. In addition, six pairs of type-specific primers (a1,
a2; b1, b2; c1, c2; d1, d2; e1, e2; f1, f2) were used to detect
serotypes a–f, respectively [2]. In a further experiment, all the
NT isolates which gave negative results in the first round of
PCR were subjected to PCR with type-specific primers in order
to detect any capsule-deficient mutants of encapsulated
strains. PCR amplification of target DNA was done with the
conditions described previously [2,5], with resolution of
amplification products on agarose 2% w ⁄v gels and visuali-
sation by staining with ethidium bromide. Fragment sizes of
amplicons were compared with those of the positive controls
and DNA micromaker size standards (E840; Amresco, Solon,
OH, USA).
RESULTS
The capsular-specific primers HI-1 and HI-2
amplified DNA sequences of c. 400 bp from 48
of the 53 isolates. The 48 capsule-positive strains
were analysed further with the six pairs of
serotype-specific primers. Serotype b-specific
bands were detected with 47 of these 48 isolates.
The remaining isolate was positive for type e.
None of the five NT isolates yielded amplification
products with the serotype-specific primers. This
finding indicated that none of these five NT
isolates possessed a capsulation locus. Only one
discrepancy was found between the results
obtained with the SAT and PCR assays, in that
one isolate was identified as NT with the SAT, but
as serotype e with the PCR method.
Table 1 shows the correlation between the
invasive H. influenzae isolates and the age, sex
and clinical diagnosis of the patients. Total isola-
tion rates were 45.3% in males and 54.7% in
females. Most (75.5%) isolates were from patients
aged < 3 years. The serotype e isolate was from
Table 1. Distribution of isolates according to the age, sex
and clinical diagnosis of patients
Patient
characteristics ⁄diagnosis
Type b
(n = 47)
Type e
(n = 1)
Non-typeable
(n = 5)
Total
(n = 53)
Sex
Male 23 0 1 24
Female 24 1 4 29
Age (years)
< 1 12 0 3 15
1–2 24 0 1 25
3–5 11 0 1 12
> 6 0 1 0 1
Clinical diagnosis
Meningitis 39 0 2 41
Sepsis 2 1 0 3
Septic arthritis 3 0 0 3
Epiglottitis 3 0 0 3
Septic pneumonia 0 0 3 3
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the blood of a 14-year-old female with sepsis. In
total, 41 (77.4%) patients had meningitis, three
had epiglottitis, three had septic arthritis, three
had sepsis, and three had pneumonia with
septicaemia. Among the 41 isolates from patients
with meningitis, 39 (95.1%) were Hib and two
(4.9%) were NT H. influenzae. Of the five patients
with invasive infection caused by NT H. influen-
zae, two had meningitis and three had pneumonia
with septicaemia. In addition, three of the five NT
isolates were from patients aged < 1 year.
DISCUSSION
Before the introduction of Hib conjugate vaccine,
serotype b H. influenzae was the leading cause of
bacterial meningitis and a common cause of other
invasive infections in infants and young children.
Several studies conducted in the USA, Ireland,
Brazil and South Korea showed that most
H. influenzae strains that caused invasive infection
were type b, while NT strains, especially encap-
sulated non-type b strains, were uncommon
[9–12]. However, following the introduction of
Hib conjugate vaccine, the incidence of Hib
invasive infections has decreased dramatically
[13]. As a consequence, invasive infections caused
by encapsulated non-type b and NT strains have
become relatively more frequent [14,15].
Conventionally, serotyping of H. influenzae
strains has been performed by standard SATs
[16]. However, these tests have been shown to be
unreliable, and a PCR serotyping method, with
high sensitivity and specificity compared with the
standard SAT, has now become available [2,5].
The usefulness of this technique for typing
H. influenzae has already been confirmed in
several studies [14,17], and the technique has
been used to investigate the incidence of invasive
infections caused by capsule-deficient mutant Hib
strains (b– strains) [18,19]. It is likely that the
single discrepant result in the present study was
caused by the low sensitivity of the antiserum,
resulting in difficulties in interpreting the SAT.
In the present study, all 53 isolates were
examined with the PCR method. With regard to
disease spectrum, the present study indicated that
meningitis cases accounted for 77% of all the
cases of invasive disease caused by Hib. The
remaining 23% of cases involved epiglottitis,
septic arthritis, sepsis and pneumonia. This dis-
tribution is similar to that reported in the USA in
the pre-vaccination era [20]. Information on the
incidence of invasive H. influenzae infections
among Japanese children has previously been
limited. According to a nationwide survey of
H. influenzae meningitis, the incidence is 4.7
cases ⁄ 100 000 ⁄ year [8]. Based on these data, the
estimated number of patients with meningitis in
the entire country during the study period was
c. 1900, so that the 41 cases in the present study
represented 2.2% of all the cases of meningitis
caused by H. influenzae in Japan. Not surprisingly,
most (88.7%) of the invasive H. influenzae isolates
were of serotype b. This finding is consistent with
the data reported previously by many investiga-
tors from other countries in the pre-vaccination
era [9–12].
The present study also confirmed the inci-
dence of invasive infections caused by NT
H. influenzae, which accounted for 9.4% of the
total. According to previous reports, some NT
H. influenzae strains show evidence of capsula-
tion sequences, suggesting that a subgroup of
NT strains is derived from an encapsulated
precursor. Such strains might be generated by
loss of their capsulation ability through homol-
ogous recombination [19], but the present study
did not identify any invasive capsule-deficient
mutants of encapsulated strains. Although the
number of isolates studied was too small to be
conclusive, the findings suggested that the inci-
dence of invasive b– strains of H. influenzae is
extremely low in Japanese paediatric infections.
Although the Hib conjugate vaccine has not yet
been introduced in Japan, this type of vaccine
may be used widely in the near future. As a
result, other encapsulated non-type b and NT
strains may then emerge as a cause of invasive
infection in the post-vaccination era. Therefore, it
is necessary to continue H. influenzae surveillance
to detect any alteration in disease-causing
H. influenzae in the community, and the informa-
tion acquired from such surveillance studies
should be exploited to institute effective vaccin-
ation strategies. The PCR-based method, with its
high sensitivity and specificity, should be valu-
able for serotyping invasive H. influenzae strains
in Japan. As suggested previously [17], although
it would be difficult to introduce this technique
into all clinical laboratories, its use should be
encouraged in reference laboratories as an accu-
rate means of monitoring H. influenzae isolates
recovered from invasive infections.
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